Acyclic phosphonomethylether nucleoside inhibitors of respiratory viruses

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 3, 1997, Pages 223-233

  Barnard, D L ^a   Bischofberger, N ^b   Kim, C U ^b   Huffman, J H ^a   Sidwell, R W ^a   Dougherty, J P ^b   Lew, W ^b   Williams, M A ^b   Yang, W ^b  

^a UTAH STATE UNIVERSITY   (United States)

^b GILEAD SCIENCES   (United States)

Author keywords

Acyclic; adenovirus; measles virus; nucleoside; parainfluenza virus 3; phosphonomethylether

Indexed keywords

9 (2 PHOSPHONYLMETHOXYETHYL)GUANINE; 9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; ANTIVIRUS AGENT; CIDOFOVIR; GS 0504; GS 0577; GS 2128; GS 2542; GS 438; NEUTRAL RED; NUCLEOSIDE DERIVATIVE; RIBAVIRIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG SYNTHESIS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MEASLES VIRUS; NONHUMAN; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; VIRUS INHIBITION;

EID: 0030906691     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800306     Document Type: Article

References (30)

1. Baba M, Mori S, Shigeta S & De Clercq E (1987) Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)-adenine and 2′-nor-cyclic GMP on adenovirus replication in vitro. Antimicrobial Agents and Chemotherapy 31: 337-339.
2. Balzarini J, Kruining J, Heijtink R & De Clercq E (1994) Comparative anti-retrovirus and anti-hepadnavirus activity of three different classes of nucleoside phosphonate derivatives. Antiviral Chemistry and Chemotherapy 5: 360-365.
3. Bronson JJ, Kim CU, Ghazzouli I, Hitchcock MJM, Kern ER &. Martin JC (1989) Synthesis and antiviral activity of phosphonylmethoxyethyl derivatives of purine and pyrimidine bases. Nucleotide Analogues 5: 73-87.
4. Calio R, Villani N, Balestra E, Sesa F, Holy A, Balzarini J, De Clercq E, Perno CF & Del Gobbo, V (1994) Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates. Antiviral Research 23: 77-89.
5. Cavenaugh Jr PR, Moskwa PS, Donish WH, Pera PJ, Richardson D & Andrese AP (1990) A semi-automated neutral red based chemosensitivity assay for drug screening. Investigational New Drugs 8: 347-354.
6. Collins PL, Hill MG, Cristina J & Grosfeld H (1996) Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proceedings of the National Academy of Sciences, USA 93: 81-85.
7. De Clercq E (1993) Therapeutic potential of HPMPC as an antiviral drug. Reviews in Medical Virology 3: 85-96.
8. De Clercq E, Holy A, Rosenberg I, Sakuma T, Balzarini J & Maudgal P (1986) A novel selective broad-spectrum anti-DNA virus agent. Nature 323: 464-465.
9. Del Gobbo V, Foli A, Balzarini J, De Clercq E, Balestra E, Villani N, Marini S, Perno CF & Calio R (1991) Immunomodulatory activity of 9-(2-phosphonyl-methoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models. Antiviral Research 16: 65-75.
10. Gordon YJ, Romanowski E, Araullo-Cruz T, Seaberg L, Erzurum S, Tolman R & De Clercq E (1991) Inhibitory effect of (s)-HPMPC (s)-HPMPA, and 2′-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Antiviral Research 16: 11-16.
11. Griffin DE & Bellini WJ (1996) Measles virus. In Fields Virology, 3rd edn. Edited by BN Fields, DM Knupe & PM Howley. Philadelphia: Lippincott-Raven, pp. 1267-1312.
12. Ho HT, Woods KL, Konrad SA, De Boeck H & Hitchcock MJ (1992) Cellular metabolism and enzymatic phosphorylation of 9-(2-phosphonylmethoxyethyl) guanine (PMEG), a potent antiviral agent. Advances in Experimental Medicine and Biology 312: 159-166.
13. Holy A (1993) Isopolar phosphorus-modified nucleotide analogues. Advances in Antiviral Drug Design 1: 179-231.
14. Holy A, De Clercq E & Votruba I (1989) Phosphonylmethyl ethers of nucleosides and their acyclic analogues. Nucleotide Analogues 4: 52-71.
15. Holy A, Votruba I, Merta A, Cerny J, VeselyJ, Vlach J, Sediva K, Rosenberg I, Otmar M, Hrebabecky H, Travnicek M, Vonka V, Snoeck R & De Clercq E (1990) Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antiviral Research 13: 295-312.
16. Kaminsky R, Zweygarth E & De Clercq E (1994) Antitrypanosomal activity of phosphonylmethoxyalkylpurines. Journal of Parasitology 80: 1026-1030.
17. Kim CU, Misco PF, Luh BY & Martin JC (1990) Synthesis of a phosphonate isostere of acyclovir monophosphate: a herpes-virus active phosphonate nucleotide analogue. Heterocycles 31: 1571.
18. Kim CU, Luh BY & Martin JC (1991a) Regiospecific and highly stereoselective electrophilic addition to furanoid glycals: synthesis of phosphonate nucleotide analogues with potent activity against HIV. Journal of Organic Chemistry 56: 2642-2647.
19. Kim CU, Misco PF, Luh BY, Hitchcock MJM, Ghazzouli I & Martin JC (1991b) A new class of acyclic phosphonate nucleotide analogues: phosphonate isosteres of acyclovir and ganciclovir monophosphates as antiviral agents. Journal of Medicinal Chemistry 34: 2286-2294.
20. Kim CU, Luh BY & Martin JC (1992) A novel synthesis of 1-oxa-HPMPA: a potent antiviral agent against herpesviruses. Tetrahedron Letters 33: 25-28.
21. Mul YM, van Miltenburg RT, De Clercq E & van der Vliet PC (1989) Mechanism of inhibition of adenovirus DNA replication by the acyclic nucleoside triphosphate analogue (S)-HPMPApp: influence of the adenovirus DNA binding protein. Nucleic Acids Research 17: 8917-8929.
22. Otova B, Krenova D, Zidek Z, Holy A, Votruba I & Kren V (1993a) Cytostatic effect of 9-(2-phosphonomethoxyethyl)-adenine (PMEA). III. Rat and mouse carcinomas and sarcomas. Folia Biologica 39: 311-314.
23. Otova B, Sladka M, Votruba I, Holy A & Kren V (1993b) Cytostatic effect of 9-(2-phosphonomethoxyethyl)adenine (PMEA). I. PMEA. Folia Biologica 39: 136-140.
24. Otova B, Zidek Z, Holy A, Votruba I & Frankova D (1994) Immunomodulatory properties of 9-(2-phosphonomethoxyethyl)-adenine (PMEA). Folia Biologica 40: 185-192.
25. Rose W, Crosswell AR, Bronson JJ & Martin JC (1990) In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]-guanine and related phosphonate nucleotide analogues. Journal of the National Cancer Institute 82: 510-512.
26. Rota JS, Hummel KB, Rota PA & Bellini WJ (1992) Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188: 135-142.
27. Rota JS, Wang ZD, Rota PA & Bellini WJ (1994) Comparison of the sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Research 31: 317-330.
28. Rota PA, Bloom AE, Vanchiere JA & Bellini WJ (1994) Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolates from recent epidemics. Virology 198: 724-730.
29. Sidwell RW & Huffman JH (1971) Use of disposable micro-tissue culture plates for antiviral and interferon induction studies. Applied Microbiology 22: 797-801.
30. Tsai C-C, Follis KE, Sabo A, Grant RF, Bartz C, Nolte RE, Benveniste RE & Bischofberger N (1994) Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl) adenine against simian immunodeficiency virus infection in macaques. Journal of Infectious Diseases 169: 260-266.